Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon's syndrome

Mayo Clinic Proceedings

Volumn 74, Issue 1, 1999, Pages 57-61

  Alan Wright, R ^a   Kokmen, Emre ^a,b  

^a MAYO CLINIC ROCHESTER   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ATROPHY; BRAIN INFARCTION; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; HUMAN; HUMAN TISSUE; LIVEDO RETICULARIS; MALE; SNEDDON SYNDROME; WHITE MATTER;

EID: 0032922287     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.1.57     Document Type: Article

References (34)

1. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965; 77:180-185
2. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990:40:464-467
3. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996:5:347-353
4. Chinnery PF, Shaw PJ, Ince PG, Jackson GH, Bishop Rl. Fulminant encephalopathy due to the catastrophic primary antiphospholipid syndrome [letter]. J A/euro/ Neurosurg Psychiatry 1997;62:300-301
5. Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987:18:1107-1112
6. Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc 1987;62:281288
7. Jastak S, Wilkinson GS. The Wide Range Achievement Test-Revised: Administration Manual. Wilmington (DE): Jastak Associates; 1984
8. Wechsler DA. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981
9. MattisS. Dementia Rating Scale: Professional Manual. Odessa (TX): Psychological Assessment Resources; 1988
10. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964
11. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger; 1983
12. Benton AL, Hamsher KdeS. Multilingual Aphasia Examination. Iowa City: AJA Associates; 1989
13. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia: Lea & Febiger; 1983. pp 1-31
14. Champion RH, Rook A. Livedo reticularis. Proc A/at/ Acad Sei USA 1960:53:961-962
15. Bruyn RPM. Sneddon's syndrome. In: Toole JF, Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of Clinical Neurology. Vol 55. New York: Elsevier; 1989. pp 401-410
16. Levine SR. Antiphospholipid antibody syndrome. In: Welch KMA, Caplan LR, Reis DJ, Siesjö BK, Weir B, editors. Primer on Cerebrovascular Diseases. San Diego: Academic Press; 1997. pp 381-384
17. Baleva M, Chauchev A, Dikova C, Stamenov B, Nikoevski N, Tzankov N, et al. Sneddon's syndrome: echocardiographic, neurological, and immunologie findings [letter]. Stroke 1995;26:1303-1304
18. Tourbah A, Piette JC, Iba-Zizen MT, Lyon-Caen 0, Godeau P, Frances C. The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997;54:53-60
19. Rebollo M, Val JF, Garijo F, Quintana F, Berciano J. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome): clinical, radiologi- cal and pathological features in eight cases. Brain 1983:106:965979
20. Rumpl E, Neuhofer J, Pallua A, Willeit J, Vogl G, Stampfel G, et al. Cerebrovascular lesions and livedo reticularis (Sneddon's syndrome)-a progressive cerebrovascular disorder? J Neurol 1985; 231:324-330
21. Geschwind DH, FitzPatrick M, Mischel PS, Cummings JL. Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology 1995;45:557-560
22. Scott IA, Boyle RS. Sneddon's syndrome. Aust N Z J Med 1986;16:799-802
23. Devuyst G, Sindic C, Laterre E, Brucher JM. Neuropathological findings of a Sneddon's syndrome presenting with dementia not preceded by clinical cerebrovascular events [letter]. Stroke 1996; 27:1008-1010
24. Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990;21:1268-1273
25. Weissenborn K, Ruckert N, Ehrenheim C, Schellong S, Goetz C, Lubach D. Neuropsychological deficits in patients with Sneddon's syndrome. J Neurol 1996;243:357-363
26. Pinol-Aguade J, Ferrandiz C, Ferrer-Roca 0, Ingelmo M. Livedo reticulares y accidentes cerebro-vasculares. Med Cutan Iber Lat Am 1975:4:257-266
27. Boortz-Marx RL, Clark HB, Taylor S, Wesa KM, Anderson DC. Sneddon's syndrome with granulomatous leptomeningeal infiltration. Stroke 1995;26:492-495
28. Quimby SR, Perry HO. Livedo reticularis and cerebrovascular accidents. J Am Acad Dermatol 1980:3:377-383
29. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. Ann Neurol 1995;37(Suppl 1):S114-S130
30. Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrezema B, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995:38:119-124
31. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N EnglJ Med 1995:332:993-997
32. Van Horn G, Arnett FC, Dimachkie MM. Reversible dementia and chorea in a young woman with the lupus anticoagulant. Neurology 1996:46:1599-1603
33. Gorman DG, Cummings JL. Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatry Clin Neumsci 1993:5:37-42
34. Folstein MF, Folstein SE, McHugh PR. "Mini mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975:12:189-198